ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells

A major drawback of tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is that primitive CML cells are able to survive TKI-mediated BCR-ABL inhibition, leading to disease persistence in patients. Investigation of strategies aiming to inhibit alternative survival pathways in...

Descripción completa

Detalles Bibliográficos
Autores principales: Karvela, Maria, Baquero, Pablo, Kuntz, Elodie M., Mukhopadhyay, Arunima, Mitchell, Rebecca, Allan, Elaine K., Chan, Edmond, Kranc, Kamil R., Calabretta, Bruno, Salomoni, Paolo, Gottlieb, Eyal, Holyoake, Tessa L., Helgason, G. Vignir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Basic Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922442/
https://www.ncbi.nlm.nih.gov/pubmed/27168493
http://dx.doi.org/10.1080/15548627.2016.1162359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922442/
https://www.ncbi.nlm.nih.gov/pubmed/27168493
http://dx.doi.org/10.1080/15548627.2016.1162359

Ejemplares similares